Which stocks have an unusual volume on Thursday? The trading volume of these stocks is deviating from the norm in today's session.
BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial
Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative's Inroads Bringing Its Stem Cell Therapies To Market Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative's Inroads Bringing Its Stem Cell Therapies To Market
BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function BioRestorative Therapies shares promising Phase 2 trial results for BRTX-100, showing significant pain reduction and functional improvement in cLDD patients.
Armed With Its Patent Portfolio, BioRestorative Therapies Has Success In The Laboratory And At The Negotiating Table: Is Profitability Close Behind? Armed With Its Patent Portfolio, BioRestorative Therapies Has Success In The Laboratory And At The Negotiating Table: Is Profitability Close Behind?
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q2 2024 BRTX stock results show that BioRestorative Therapies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
What's Going On With BioRestorative Therapies Stock? BioRestorative Therapies shares are trading higher Monday after the company announced it has received notice from the Nasdaq Stock Market that it has regained compliance with listing requirements.
Why BioRestorative Therapies Stock Is Moving Higher Thursday BioRestorative Therapies announced before the market opened on Thursday that it engaged in substantive licensing discussions with a regenerative medicine company related to its ThermoStem Metabolic Disease Program intellectual property.
Why Is Sharps Technology (STSS) Stock Up 21% Today? Sharps Technology stock is up on Thursday with heavy trading of STSS shares after the company signed a $30 million purchase order.
Why Is BioRestorative Therapeutics (BRTX) Stock Up 42% Today? BioRestorative Therapeutics stock is up on Thursday with heavy trading of BRTX shares after announcing licensing negotiations.
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q1 2024 BRTX stock results show that BioRestorative Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
